USFDA conducts inspection at Zydus group’s formulation plant in Ahmedabad

14 Aug 2025 Evaluate

United States Food and Drug Administration (USFDA) has conducted an inspection at the Zydus group’s formulation manufacturing plant located SEZ -- II, Ahmedabad. The inspection was a Pre-Approval Inspection (PAI) for 3 products with general cGMP and was conducted from August 11 to August 13, 2025. The inspection concluded with NIL observations.

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.

Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×